Welcome: Guest | Site Use Options | Register | Login |

AbbVie amps up 'armed antibody' deal with Seattle Genetics to the tune of $255M

Awardee Story AbbVie amps up 'armed antibody' deal with Seattle Genetics to the tune of $255M
Date: Jan 28, 2014
Author: Tracy Staton
Source: FiercePharma ( click here to go to the source)

Whatever AbbVie ($ABBV) learned in the first stages of its collaboration with Seattle Genetics ($SGEN) on antibody-drug conjugates must have seriously whetted the pharma company's appetite. AbbVie is now paying $25 million upfront and up to $255 million more in milestones for each new target they tackle in a greatly expanded partnership.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com